Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Insulin ResistanceHypertriglyceridemia
Interventions
DRUG

Rosiglitazone

DRUG

Fenofibrate

BEHAVIORAL

Weight Loss

Trial Locations (1)

94305

Stanford University Medical Center, Stanford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Stanford University

OTHER